Journals / MN Kardiyoloji / 2020 / Cilt: 27 - Sayı: 3

Retrospective Analysis of 24 Cases of Cardiac Myxomas: A Single Center Experience

Kardiyak Miksomalı 24 Vakanın Geriye Dönük Analizi: Tek Merkez Deneyimi

Pages
130–135
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although echocardiography is the main diagnostic tool, surgical resection with pathologic assessment remain the gold standard.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, the outcomes of operated intracardiac massess which diagnosed as cardiac myxoma after histopathological evaluation were reported.
📊
Key Findings & Data:Material and Method: The study included a total of 50 patients who were operated for intracardiac mass between September 2012 and August 2019.
💡
Conclusion & Impact:Although echocardiography is the main diagnostic tool, surgical resection with pathologic assessment remain the gold standard.
🔬Design:Review & Systematic Survey
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, the outcomes of operated intracardiac massess which diagnosed as cardiac myxoma after histopathological evaluation were reported. Material and Method: The study included a total of 50 patients who were operated for intracardiac mass between September 2012 and August 2019. Among them, a total of 24 patients (17 females, 7 males, mean age 53.2±17.2 years; range 20 to 81 years) with histopathological diagnosis of cardiac myxoma were retrospectively reviewed. Preoperative diagnosis was made by transthoracic echocardiography. The mean time to the last follow-up visit was 2.5±1.8 years. Results: All patients were operated through median sternotomy. The average age of the patients was 53.2±17.2 years. 17 (70.8%) of them were female. The most common symptom was dyspnea. An embolic event was noted in 12.5% of patients. Myxomas were mostly located in the left atrial/interatrial septum. There was no in-hospital mortality. A total of 2 (8.3%) patients showed tumor recurrence and two patients died of non cardiac causes during the follow-up. Conclusions: Cardiac myxoma is associated with a low morbidity and mortality. Although echocardiography is the main diagnostic tool, surgical resection with pathologic assessment remain the gold standard.

Özet

Amaç: Merkezimizde intrakardiyak kitle tanısı ile opere edilen ve histopatolojik olarak miksoma tanısı konulan hastaların sonuçlarını bildirmek. Gereç ve Yöntem: Eylül 2012-Ağustos 2019 tarihleri arasında intrakardiyak kitle tanısıyla ameliyat edilen toplam 50 hastadan histopatolojik olarak miksoma tanısı konulan 24 hasta (17 kadın, 7 erkek, ortalama yaş 53,2±17,2 yıl; dağılım 20-81 yıl) retrospektif olarak incelendi. Ameliyat öncesi tanı transtorasik ekokardiyografiyle ile konuldu. Son takip vizitine kadar geçen ortalama süre 2,5±1,8 yıl idi. Bulgular: Tüm hastalar medyan sternotomi ile ameliyat edildi. Hastaların ortalama yaşı 53,2±17,2 yıl idi. 17 (%70,8) hastanın cinsiyetikadın, en sık görülen semptom dispne idi. Hastaların %12,5’inde geçirilmiş bir emboli atağı mevcuttu. Miksomalar en sık sol atriyum interatriyal septumdan köken almakta idi. Hastane içi ölüm görülmedi. Takip süresince 2 (%8,3) hastada nüks, 2 hastada ise kardiyovasküler nedenlere bağlı olmayan ölüm görüldü. Sonuç: Kardiyak miksoma düşük morbidite ve mortalite ile ilişkilidir. Ekokardiyografi ana tanısal araç olsa da cerrahi rezeksiyon ve patolojik değerlendirme altın standarttır.

🔖

Cite This Article

KOZA, Y. (2020). Retrospective Analysis of 24 Cases of Cardiac Myxomas: A Single Center Experience. MN Kardiyoloji, Cilt: 27 - Sayı: 3, 130–135. https://ajindex.com/articles/297195

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Lam KY. Dickens P. Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. 1993;117(10):1027-31
  2. Roschkov S. Rebeyka D. Mah J. Urquhart G. The dangers of cardiac myxomas. Prog Cardiovasc Nurs. 2007;22(1):27-30
  3. Jain S. Maleszewski JJ. Stephenson CR. Klarich KW. Current diagnosis and management of cardiac myxomas. Expert Rev Cardiovasc Ther. 2015;13(4):369-75
  4. Jiang CX. Wang JG. Qi RD. et al. Long-term outcome of patients with atrial myxoma after surgical intervention: analysis of 403 cases. J Geriatr Cardiol. 2019;16(4):338-43
  5. Hong YJ. Hur J. Kim YJ. et al. Dual-energy cardiac computed tomography for differentiating cardiac myxoma from thrombus. Int J Cardiovasc Imag. 2014;30(Suppl2):121-8
  6. Pinede L. Duhaut P. Loire R. Clinical presentation of left at - ri al cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore). 2001;80(3):159-72
  7. Oliveira R. Branco L. Galrinho A. et al. Cardiac myxoma: a 13-year experience in echocardiographic diagnosis. Rev Port Cardiol. 2010;29(7-8):1087-100
  8. Garcia-Carretero R. Vela BB. Martínez-Quesada G. San Jose Montano B. Demographic and clinical features of atrial myxomas: a case series analysis. Acute Card Care. 2016;18(3):65-9
  9. Reber D. Birnbaum DE. Recurrent cardiac myxoma: why it occurs. A case report with literature review. J Cardiovasc Surg (Torino). 2001;42(3):345-8
  10. Fan J. Chen W. Huang F. Chen X. Clonal Origin Patterns Play a Vital Role in Cardiac Myxoma Recurrence. Ann Clin Lab Sci. 2019;49(4):468-73
  11. Hoey ET. Shahid M. Ganeshan A. Baijal S. Simpson H. Watkin RW. MRI assessment of cardiac tumours: part 1, multiparametric imaging protocols and spectrum of appearances of histologically benign lesions. Quant Imag Med Surg. 2014;4(6):489-97
  12. Poterucha TJ. Kochav J. O'Connor DS. Rosner GF. Cardiac Tu mors: Clinical Presentation, Diagnosis, and Manage - ment. Curr Treat Options Oncol. 2019;20(8):66
  13. Colin GC. Gerber BL. Amzulescu M. Bogaert J. Cardiac myxoma: a contemporary multimodality imaging review. Int J Cardiovasc Imaging. 2018;34(11):1789-808
  14. Di Vito A. Mignogna C. Donato G. The mysterious pathways of cardiac myxomas: a review of histogenesis, pathogenesis and pathology. Histopathology 2015;66(3):321-32
  15. Yuan SM. Yan SL. Wu N. Unusual aspects of cardiac myxoma. Anatol J Cardiol. 2017;17(3):241-7
  16. Nuño IN. Kang TY. Arroyo H. Starnes VA. Synchronous Cardiac Myxoma and Colorectal Cancer